BMRN

59.9202.44%
BR

Brian R. Mueller

CFO & Executive VP of Finance

Mr. Brian R. Mueller is Treasurer of Amicus Therapeutics, Inc. from April 27, 2026. Mr. Mueller serves as Director at Inozyme Pharma, Inc since July 01, 2025. He serves as Chief Financial Officer at BioMarin Pharmaceutical Inc. and has been Executive Vice President of Finance since June 2020 and served as its Principal Accounting Officer since September 2, 2025 until January 19, 2026. He served as the Chief Accounting Officer of BioMarin Pharmaceutical Inc. since March 2, 2011 until June 2020 and served as its Acting Chief Financial Officer since January 29, 2020 until June 2020. He joined the BioMarin Pharmaceutical Inc. in December 2002. Mr. Muelle served as Senior Vice President of Finance at BioMarin Pharmaceutical Inc until June 2020 and served as its Group Vice President. From March 2014 to August 2016, Mr. Mueller served as Group Vice President and Corporate Controller at BioMarin Pharmaceutical Inc and Vice President and Corporate Controller and from March 2009 to March 2014. He joined BioMarin in December 2002. Prior to joining BioMarin, he worked in the San Francisco office of KPMG LLP as a Senior Manager in its audit practice. He joined KPMG LLP in June 2002 and served at Arthur Andersen LLP in its Audit and Business Advisory services practices in Chicago and San Francisco. His public accounting experience includes accounting, audit and business advisory services for both domestic and multi-national publicly held companies within a variety of industries, primarily manufacturing and consumer products. He served as a Director of Anthera Pharmaceuticals, Inc. since June 23, 2014. He is a Member of the American Institute of Certified Public Accountants. Mr. Mueller received a B. S. in Accountancy from Northern Illinois University in DeKalb, Illinois.

Positions